external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

Researchers have developed a new gene-editing technique called bridge editing, to precisely insert large DNA sequences into the human genome without causing harmful DNA breaks, offering a safer and more efficient method for treating genetic disorders.

Featured Articles.

PHARMA

Breakthrough "Armoured" CAR T-Cell Therapy Shows Promising Results in Tough-to-Treat Lymphomas

PHARMA

Pfizer Halts Development of Oral GLP-1 Agonist Danuglipron Amid Liver Safety Signal

BIOTECH

Immunocore Unveils Promising HIV Functional Cure Data at CROI 2025

BIOTECH

Magnetic Bead Separation: More Than Just a Magnet

HEALTH

Healthcare Policy: Myeloma UK's Call for Equitable NHS Access to CAR-T Cell Treatment

SUSTAINABILITY

A Modern-Day Noah's Ark?

PHARMA

Women’s Health Therapeutics Market Enters Transformative Growth Phase

BIOPROCESSING

Navigating the Digitalisation Journey in the Biopharmaceutical Industry

HEALTH

Training the Immune System to Outlast Cancer

Latest News.

22nd May, 2025

01. PeproMene Bio Reports Complete Remission in First Follicular Lymphoma Patient from Phase 1 Trial

BAFFR-targeted CAR T cell therapy shows promise in treating relapsed follicular lymphoma.

17th May, 2025

02. FDA Clears Blood Test for Diagnosing Alzheimer’s Disease

The FDA has approved a new plasma-based biomarker assay, the first blood-based diagnostic for Alzheimer's disease, offering a less invasive and more accessible alternative to traditional methods like PET scans and spinal taps.

9th May, 2025

03. A Millennia-Old Mutation with Modern Implications

A genetic mutation known as CCR5Δ32, originating between 6,700 and 9,000 years ago near the Black Sea, provided ancient humans with a controlled immune response to emerging pathogens and now plays a crucial role in modern HIV resistance and gene-editing therapies.

9th May, 2025

04. UK-US Trade Deal: What's in it for Pharma?

Despite the UK securing an initial trade agreement with the US, the pharmaceutical sector remains uncertain, as the deal notably omits specific provisions for medicines, leaving the industry awaiting clearer terms regarding potential tariffs and preferential treatment.